Pipeline
Barinthus Biotherapeutics’ portfolio of antigen-specific immunotherapies:
Key Programs
We believe that the SNAP-TI platform has the potential to impact multiple additional I&I indications.
Other Programs
These are estimated timelines only and our pipeline may be subject to change.
Updated: 15 January 2025